G. Gökhan Et Al. , "The Evaluation of Apoptosis and Cytotoxicity of Bortezomib, an Approved Proteasome Inhibitor, in K562 and HL-60 Cell Lines," IVEK 3rd International Convention of Pharmaceuticals and Pharmacies , İstanbul, Turkey, 2017
Gökhan, G. Et Al. 2017. The Evaluation of Apoptosis and Cytotoxicity of Bortezomib, an Approved Proteasome Inhibitor, in K562 and HL-60 Cell Lines. IVEK 3rd International Convention of Pharmaceuticals and Pharmacies , (İstanbul, Turkey).
Gökhan, G., DİKMEN, M., CANTÜRK, Z., & Fatma, G., (2017). The Evaluation of Apoptosis and Cytotoxicity of Bortezomib, an Approved Proteasome Inhibitor, in K562 and HL-60 Cell Lines . IVEK 3rd International Convention of Pharmaceuticals and Pharmacies, İstanbul, Turkey
Gökhan, Gökhaner Et Al. "The Evaluation of Apoptosis and Cytotoxicity of Bortezomib, an Approved Proteasome Inhibitor, in K562 and HL-60 Cell Lines," IVEK 3rd International Convention of Pharmaceuticals and Pharmacies, İstanbul, Turkey, 2017
Gökhan, Gökhaner Et Al. "The Evaluation of Apoptosis and Cytotoxicity of Bortezomib, an Approved Proteasome Inhibitor, in K562 and HL-60 Cell Lines." IVEK 3rd International Convention of Pharmaceuticals and Pharmacies , İstanbul, Turkey, 2017
Gökhan, G. Et Al. (2017) . "The Evaluation of Apoptosis and Cytotoxicity of Bortezomib, an Approved Proteasome Inhibitor, in K562 and HL-60 Cell Lines." IVEK 3rd International Convention of Pharmaceuticals and Pharmacies , İstanbul, Turkey.
@conferencepaper{conferencepaper, author={Gökhaner Gökhan Et Al. }, title={The Evaluation of Apoptosis and Cytotoxicity of Bortezomib, an Approved Proteasome Inhibitor, in K562 and HL-60 Cell Lines}, congress name={IVEK 3rd International Convention of Pharmaceuticals and Pharmacies}, city={İstanbul}, country={Turkey}, year={2017}}